FIELD: molecular biology; biochemistry; medicine; pharmacology.
SUBSTANCE: invention relates to imidazolidine-2,4-dione and imidazolidine-2,4,5-trione derivatives, which are 1-(((1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methyl)-3-phenylimidazolidine-2,4-dione (I) and 1-(2-adamantyl)-3-((1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-yl)imidazolidine-2,4,5-trion (II).
EFFECT: compounds of formulas (I) and (II), which are capable in non-cytotoxic concentrations to reduce the ability of GBM cells of grafted lines to migration (in scratch overgrowth test) by 30–37%.
1 cl, 4 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
1,1'-(HEXANE-1,6-DIYL)BIS(3-(((1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTAREN-1-YL)METHYL)UREA, WHICH EXHIBITS INHIBITING ACTION ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME AND INCREASES TEMOZOLOMIDE ACTIVITY ON GLIOBLASTOMA CELLS | 2019 |
|
RU2724882C1 |
1-ADAMANTYL-3-(((1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHREN-1-YL)METHYL)UREA, WHICH EXHIBITS INHIBITING ACTION ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME AND INCREASES ACTIVITY OF TEMOZOLOMIDE AGAINST GLIOBLASTOMA CELLS | 2019 |
|
RU2697409C1 |
7-TRIAZOLYL-SUBSTITUTED HYDROXYSPYROSTANES WITH CYTOTOXIC ACTIVITY AGAINST HUMAN TUMOR CELLS | 2023 |
|
RU2798105C1 |
AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814738C1 |
ARGLABIN DERIVATIVES WITH SELECTIVE CYTOTOXIC EFFECTS | 2023 |
|
RU2805915C1 |
AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814259C1 |
CARBOXAMIDES OF ISOPIMARIC ACID, HAVING ANALGESIC ACTIVITY | 2019 |
|
RU2726613C1 |
NEW STERICALLY HINDERED PHENOLS CONTAINING BENZOFUROXAN FRAGMENTS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2796810C1 |
BROMINE-CONTAINING STERICALLY HINDERED PHENOLS WITH ANTICANCER ACTIVITY | 2023 |
|
RU2822270C1 |
((3Β-ACETOXY-URS-12-EN-28-OYL-OXYACETOXY)METHYL)-1H-1,2,3-TRIAZOL-1-YL)METHYL)-4-METHYL-1,2,5-OXADIAZOL-2-OXIDE, HAVING SELECTIVE ANTICANCER ACTIVITY AGAINST MCF-7 BREAST CANCER CELLS | 2020 |
|
RU2739559C1 |
Authors
Dates
2024-06-17—Published
2023-12-08—Filed